Thermo Fisher's trading volume on February 18 was $1.356 billion, ranking 64th among U.S. stocks on that day.

2026-02-19 06:28:35

Abstract generation in progress

On February 18, 2026, Thermo Fisher Scientific (TMO), a life sciences tools and services company, had a trading volume of $1.356 billion, ranking 64th among U.S. stocks that day. The trading volume decreased by 28.54% compared to the previous day, with a daily trading volume of 2.6622 million shares.

On February 18, 2026, Thermo Fisher Scientific (TMO) rose 2.39%, closing at $513.56. The stock declined by 2.58% over the past five trading days, down 11.24% for February, and has fallen 11.37% since the beginning of the year. Over the past 52 weeks, it has decreased by 1.82%.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to companies listed for less than 1 month or fewer than 5 trading days).

Thermo Fisher Scientific (TMO)	Trading Volume / USD	Change in Trading Volume from Yesterday	Volume
February 18, 2026	$1.356 billion	-28.54%	2.6622 million
February 17, 2026	$1.897 billion	17.68%	3.7754 million
February 13, 2026	$1.612 billion	-32.84%	3.1884 million
February 12, 2026	$2.401 billion	35.42%	4.7421 million
February 11, 2026	$1.773 billion	61.67%	3.3676 million

Thermo Fisher Scientific is a Delaware corporation. The company is a global leader in scientific services. Its mission is to enable customers to make the world healthier, cleaner, and safer. The company serves clients in pharmaceutical and biotech companies, hospitals and clinical diagnostic laboratories, universities, research institutions, government agencies, as well as in environmental, industrial, R&D, quality, and process control environments. Its global team offers unparalleled innovative technologies, purchasing convenience, and a portfolio of pharmaceutical services through industry-leading brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.